<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45096">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01705626</url>
  </required_header>
  <id_info>
    <org_study_id>TRAP 08-2012</org_study_id>
    <nct_id>NCT01705626</nct_id>
  </id_info>
  <brief_title>Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy</brief_title>
  <acronym>TTR-FAP</acronym>
  <official_title>TTR-FAP Screening - Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy - a National, Multicentre, Epidemiological Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rostock</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Rostock</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the prevalence of patients with a polyneuropathy
      of undetermined etiology based on the normal results of laboratory data (CRP, glucose,
      electrolytes, urea, transaminases, TSH, immunoglobulins, cryoglobulins, vitamin B12, RF,
      ANA, antibodies against Lyme borrelia, HIV, anti-GM1 antibodies) and CSF; no anamnesis for
      carcinoma, no continuous alcohol consumption; no light-chain-amyloidosis; no anamnesis for
      heavy metal exposure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diseases of diverse etiology can be correlated to the term polyneuropathy(PNP). The
      pathogenesis may be of inflammatory, autoimmune, metabolic, toxic or hereditary nature.
      Careful clinical and electrodiagnostic assessment, with attention to the pattern of
      involvement and the types of nerve fibers most affected, narrows the differential diagnosis
      and helps to focus the laboratory evaluation. Beside the frequent genetic etiologies in PNP
      (pmp22, MFN2) one cause of a polyneuropathy may be a hereditary amyloidosis. This term
      describes the accumulation of misfolded protein in the interstitial space. The abnormal
      accumulation of β-fibrils can be detected histologically by Congo pink staining. Aside from
      acquired amyloidotic neuropathies (e.g. PNP caused by AL-amyloidosis [AL=amyloidosis with
      light chain immunoglobins]) there are also hereditary amyloidotic neuropathies.These have
      been described as endemic in Sweden, Portugal or Japan. More recent studies provided
      evidence for the presence of hereditary amyloidotic neuropathies amongst the German
      population and that they are currently underdiagnosed.  The most common form of the
      hereditary familial amyloidotic neuropathy (FAP) is the Transthyretin-related FAP, however
      two other amyloidogenic proteins have been described: Apolipoprotein A-I and Gelsolin.

      This study focuses on TTR-FAP, whose prevalence shall be determined in a cohort of 500
      patients with polyneuropathy of unknown etiology. The TTR-FAP is an autosomal dominant
      disease, the exact prevalence of which is unknown but estimated to be around 1:100,000 to
      1:1,000,000 in the normal population.By limiting the study population to patients with PNP
      of unknown etiology it should be possible to gain evidence for the prevalence of the disease
      in Germany by investigating fewer patients.

      While the diagnosis of the amyloidotic neuropathy can be conducted histologically, a
      molecular genetic approach is necessary to diagnose TTR-FAP. Even though more than 100 point
      mutations are known to cause the disease, the most common amino acid change is V30M.The
      mutation in the TTR gene causes the destabilization of the physiologically tetrameric
      protein. Usually transthyretin consists of four identical monomeric subunits and binds the
      thyroxin circulating in the blood plasma. The monomeric subunits exhibit a pronounced
      β-sheet structure which leads to the accumulation of unsoluble β-fibrils when they are
      destabilized as in TTR-FAP.This accumulation of misfolded TTR can lead to three phenotypes
      known as-cardiac TTR amyloidosis,

      - leptomeningeal TTR amyloidosis and the TTR-FAP.The TTR-FAP has a very heterogeneous
      phenotype which can manifest starting at the age of 18 and may lead to death within 10
      years. The symptoms can be categorized in three groups
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">550</enrollment>
  <condition>Polyneuropathies</condition>
  <condition>Amyloidosis</condition>
  <condition>Amyloid Neuropathies</condition>
  <condition>Amyloidosis, Familial</condition>
  <condition>Metabolic Diseases</condition>
  <arm_group>
    <arm_group_label>Observation</arm_group_label>
    <description>all adult patients at 18 years with a polyneuropathy of undetermined etiology based on the normal results of laboratory data (CRP, glucose, electrolytes, urea, transaminases, TSH, immunoglobulins, cryoglobulins, vitamin B12, RF, ANA, antibodies against Lyme borrelia, HIV, anti-GM1 antibodies) and CSF; no anamnesis for carcinoma, no continuous alcohol consumption; no light-chain-amyloidosis; no anamnesis for heavy metal exposure</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      For the molecular genetic diagnosis of the disease TTR-FAP a sequencing of the entire TTR
      gene in all study patients will be performed. Dried blood spots will be used for this
      procedure.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        adult Patients with a polyneuropathy of undetermined etiology based on the normal results
        of laboratory data (CRP, glucose, electrolytes, urea, transaminases, TSH, immunoglobulins,
        cryoglobulins, vitamin B12, RF, ANA, antibodies against Lyme borrelia, HIV, anti-GM1
        antibodies) and CSF; no anamnesis for carcinoma, no continuous alcohol consumption; no
        light-chain-amyloidosis; no anamnesis for heavy metal exposure
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent will be obtained from the patient before any study related
             procedures

          -  Patients with a polyneuropathy of undetermined etiology based on the normal results
             of laboratory data (CRP, glucose, electrolytes, urea, transaminases, TSH,
             immunoglobulins, cryoglobulins, vitamin B12, RF, ANA, antibodies against Lyme
             borrelia, HIV, anti-GM1 antibodies) and CSF; no anamnesis for carcinoma, no
             continuous alcohol consumption; no light-chain-amyloidosis; no anamnesis for heavy
             metal exposure

          -  Patients older than 18 years of age

          -  Progressive idiopathic polyneuropathy

        Exclusion Criteria:

          -  No Informed consent from the patient before any study related procedures

          -  Patients younger than 18 years of age

          -  The etiology of the polyneuropathy is already known based on the pathological results
             of laboratory data (CRP, glucose, electrolytes, urea, transaminases, TSH,
             immunoglobulins, cryoglobulins, vitamin B12, RF, ANA, antibodies against Lyme
             borrelia, HIV, anti-GM1 antibodies) and pathological CSF; anamnesis for carcinoma,
             continuous alcohol consumption or light-chain-amyloidosis or anamnesis for heavy
             metal exposure

          -  No progression within the last two years
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arndt Rolfs, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rostock, Albrecht-Kossel-Institute for Neuroregeneration</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universität Innsbruck, Neuologische Klinik</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum der RWTH Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Altenburger Land GmbH, Klinik für Neurologie</name>
      <address>
        <city>Altenburg</city>
        <zip>04600</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fachklinik für Physikalisch Medizin und Medizinische Rehabilitation, Buchberg-Klinik</name>
      <address>
        <city>Bad Tölz</city>
        <zip>83646</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Hohe Warte, Klinik für Neurologie</name>
      <address>
        <city>Bayreuth</city>
        <zip>95445</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kliniken Beelitz GmbH, Neurologische Reha-Kliniken</name>
      <address>
        <city>Beelitz</city>
        <zip>14547</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vivantes Netzwerk, Auguste Viktoria Klinikum, Klinik für Neurologie</name>
      <address>
        <city>Berlin</city>
        <zip>12157</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jüdisches Krankenhaus Berlin, Klinik für Neurologie</name>
      <address>
        <city>Berlin</city>
        <zip>13347</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Josef Hospital, Universitätsklinik Bochum, Klinik für Neurologie</name>
      <address>
        <city>Bochum</city>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MVZ Dreiländereck</name>
      <address>
        <city>Boizenburg</city>
        <zip>19258</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus Celle</name>
      <address>
        <city>Celle</city>
        <zip>29223</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Dachau, Neurologisches u. Schlafmedizinisches Zentrum</name>
      <address>
        <city>Dachau</city>
        <zip>85221</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bezirksklinikum Mainkofen, Klinik für Neurologie</name>
      <address>
        <city>Deggendorf</city>
        <zip>94469</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Dessau, Klinik für Neurologie mit klinischer Neurophysiologie</name>
      <address>
        <city>Dessau</city>
        <zip>06847</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikzentrum Mitte, Neurologische Klinik</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Martin Gropius Krankenhaus, Klinik für Neurologie</name>
      <address>
        <city>Eberswalde</city>
        <zip>16225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alfried Krupp Krankenhaus, Rüttenscheid, Klinik für Neurologie</name>
      <address>
        <city>Essen</city>
        <zip>45131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen, Neurologische Klinik</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Greifswald, Klinik und Poliklinik für Neurologie</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Görlitz gGmbH, Neurologische Klinik</name>
      <address>
        <city>Görlitz</city>
        <zip>02828</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KMG Klinikum Güstrow GmbH, Klinik für Neurologie</name>
      <address>
        <city>Güstrow</city>
        <zip>18273</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Martha-Maria Halle-Dölau gGmbH, Akademisches Lehrkrankenhaus der Martin-Luther-Universität Halle</name>
      <address>
        <city>Halle</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf, Kopf-u.Neurozentrum, Klinik für Neurologie,</name>
      <address>
        <city>Hamburg</city>
        <zip>20251</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena, Klinikum für Neurologie</name>
      <address>
        <city>Jena</city>
        <zip>07747</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KliUniversitätsklinikum Leipzig - AöR, Klinik und Poliklinik für Neurologie</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DRK-Schmerz-Zentrum Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55127</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurologische Klinik am Johannes-Wesling-Klinikum Minden</name>
      <address>
        <city>Minden</city>
        <zip>32429</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hainich Klinikum Mühlhausen</name>
      <address>
        <city>Mühlhausen</city>
        <zip>99974</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dietrich Bonhoeffer Klinikum, Klinik für Neurologie</name>
      <address>
        <city>Neubrandenburg</city>
        <zip>17036</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurologische Klinik Ruppiner Kliniken GmbH</name>
      <address>
        <city>Neuruppin</city>
        <zip>16816</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kreiskrankenhaus Prignitz, Klinik für Neurologie</name>
      <address>
        <city>Perleberg</city>
        <zip>19348</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Josefs-Krankenhaus Potsdam</name>
      <address>
        <city>Potsdam</city>
        <zip>14471</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arztpraxis für Neurologie und Psychiatrie</name>
      <address>
        <city>Ribnitz Damgarten</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rostock, Albrecht Kossel Institute</name>
      <address>
        <city>Rostock</city>
        <zip>18147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Saarbrücken, Neurologische Klinik</name>
      <address>
        <city>Saarbrücken</city>
        <zip>66119</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kreiskrankenhaus Sigmaringen, Klinik fürNeurologie</name>
      <address>
        <city>Sigmaringen</city>
        <zip>72488</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Fachklinik Brandenburg</name>
      <address>
        <city>Teupitz</city>
        <zip>15755</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Johannes Krankenhaus</name>
      <address>
        <city>Troisdorf-Sieglar</city>
        <zip>53844</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NeuroPoint</name>
      <address>
        <city>Ulm</city>
        <zip>89073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arztpraxis für Neurologie Neue Mitte</name>
      <address>
        <city>Ulm</city>
        <zip>89073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm, Klinik für Neurologie</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sophien-u.Hufeland-Klinikum Klinik für Neurologie und Klinische Neurophysiologie</name>
      <address>
        <city>Weimar</city>
        <zip>99425</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fachkrankenhaus Hubertusburg, Klinik für Neurologie</name>
      <address>
        <city>Wermsdorf</city>
        <zip>04779</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.albrecht-kossel-institut.de</url>
  </link>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 4, 2014</lastchanged_date>
  <firstreceived_date>October 9, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rostock</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Arndt Rolfs</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>Peripheral Nervous System Diseases</keyword>
  <keyword>Neuromuscular Diseases</keyword>
  <keyword>Nervous System Diseases</keyword>
  <keyword>Metabolism, Inborn Errors</keyword>
  <keyword>Genetic Diseases, Inborn</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Amyloidosis</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Polyneuropathies</mesh_term>
    <mesh_term>Amyloid Neuropathies</mesh_term>
    <mesh_term>Amyloidosis, Familial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
